APOE Allele Frequencies in Patients With β-Thalassemia Major and Controls Stratified by Cardiac Status
| Patient Group* . | APOE Alleles (%) . | ||
|---|---|---|---|
| ε2 . | ε3 . | ε4 . | |
| A (n = 151) | 5.6 | 86.4 | 7.9 |
| B (n = 53) | 4.7 | 83.0 | 12.3 |
| C (n = 47) | 6.4 | 80.9 | 12.8 |
| Controls (n = 216) | 5.3 | 88.2 | 6.5 |
| Patient Group* . | APOE Alleles (%) . | ||
|---|---|---|---|
| ε2 . | ε3 . | ε4 . | |
| A (n = 151) | 5.6 | 86.4 | 7.9 |
| B (n = 53) | 4.7 | 83.0 | 12.3 |
| C (n = 47) | 6.4 | 80.9 | 12.8 |
| Controls (n = 216) | 5.3 | 88.2 | 6.5 |
*n refers to number of patients, while allele frequencies were calculated based on actual numbers of alleles.